ストックスクリーナーアプリを入手
38.88
3.88%
-1.57
アフターアワーズ：
38.88
前日終値:
$40.45
開ける：
$40.07
24時間の取引高:
144.27K
Relative Volume:
1.28
時価総額：
$582.31M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-15.61%
1か月 パフォーマンス:
+3.96%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$37.50
$40.30
1週間の範囲:
$37.50
$48.63
52週間の値動き範囲:
$15.00
$48.63
Tectonic Therapeutic Inc Stock (TECX) Company Profile
TECX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| TECX | 38.88 | 582.31M | 0 | 0 | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Tectonic Therapeutic Inc (TECX) 最新ニュース
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $69.00 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High Following Analyst Upgrade - Defense World
Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst Upgrade - Defense World
Tectonic Therapeutic Inc. Reports Q3 2024 Results - Yahoo Finance
BML Capital Management LLC Sells 254,295 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain - Simply Wall St
Tectonic Therapeutic price target raised to $79 from $55 at Wells Fargo - TipRanks
Tectonic Therapeutic Announces Positive Phase 1a Results in - GlobeNewswire
Tectonic's TX45 Shows Strong Phase 1 Results: 42% Renal Flow Boost, 20-Day Half-Life | TECX Stock News - StockTitan
Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.38 - Defense World
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $68.50 - Defense World
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives $23.83 Average PT from Analysts - Defense World
Vitro Diagnostics (OTCMKTS:VODG) and Tectonic Therapeutic (NASDAQ:TECX) Critical Comparison - Defense World
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 12-Month HighStill a Buy? - MarketBeat
Mineralys Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High – Still a Buy? - Defense World
Reviewing Tectonic Therapeutic (NASDAQ:TECX) and Mesoblast (NASDAQ:MESO) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year HighTime to Buy? - MarketBeat
X4 Pharmaceuticals (NASDAQ:XFOR) vs. Tectonic Therapeutic (NASDAQ:TECX) Critical Analysis - Defense World
Tectonic Therapeutic Independent Director Acquires 7.0% More Stock - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High on Insider Buying Activity - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High Following Insider Buying Activity - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Director Acquires $10,077,000.00 in Stock - MarketBeat
Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock By Investing.com - Investing.com Australia
Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock - Investing.com India
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - The Manila Times
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024 - The Bakersfield Californian
Tectonic Therapeutic: Interesting CV Disease Drug Developer (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Short Interest in Tectonic Therapeutic (NASDAQ:TECX) Increases By 258.0% - MarketBeat
Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 4.5%Here's Why - MarketBeat
Vida Ventures Advisors LLC Takes $31.17 Million Position in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome - Yahoo Finance
89,029 Shares in Tectonic Therapeutic (NASDAQ:TECX) Acquired by Renaissance Technologies LLC - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Hits New 52-Week HighHere's Why - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading 5.8% Higher - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 7% - MarketBeat
Navigating Uncertainty: Tectonic Therapeutic’s Clinical Data Volatility and Its Impact on Business Stability - TipRanks
Insider Activity Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com Nigeria
Tectonic Therapeutic director buys shares worth over $1.4 million By Investing.com - Investing.com South Africa
Timothy A. Springer Acquires 50,000 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - Defense World
Tectonic Therapeutic director buys shares worth over $1.4 million - Investing.com India
Tectonic Therapeutic (NASDAQ:TECX) Short Interest Update - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Affinity Asset Advisors LLC Makes New Investment in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Inc (TECX) 財務データ
Tectonic Therapeutic Inc (TECX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
3.66%
1.11%
大文字化:
|
ボリューム (24 時間):